Gedeon Richter Pays $263.5m For Ex-US Rights To Janssen’s Evra
‘Milestone Deal’ Will Unfold ‘Significant Synergies’
Hungarian firm Gedeon Richter is to expand further its sizeable women’s health portfolio after agreeing to acquire Janssen’s Evra (ethinyl estradiol/norelgestromin) transdermal patch outside of the US for more than a quarter of a billion dollars.
